Your browser doesn't support javascript.
loading
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.
Whittaker, Matthew K; Bendzunas, George N; Shirani, Mahsa; LeClair, Timothy J; Shebl, Bassem; Dill, Taylor C; Coffino, Philip; Simon, Sanford M; Kennedy, Eileen J.
Afiliação
  • Whittaker MK; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
  • Bendzunas GN; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
  • Shirani M; Laboratory of Cellular Biophysics, The Rockefeller University, New York, New York 10065, United States.
  • LeClair TJ; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
  • Shebl B; Laboratory of Cellular Biophysics, The Rockefeller University, New York, New York 10065, United States.
  • Dill TC; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
  • Coffino P; Laboratory of Cellular Biophysics, The Rockefeller University, New York, New York 10065, United States.
  • Simon SM; Laboratory of Cellular Biophysics, The Rockefeller University, New York, New York 10065, United States.
  • Kennedy EJ; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
ACS Chem Biol ; 19(9): 1888-1895, 2024 Sep 20.
Article em En | MEDLINE | ID: mdl-39137166
ABSTRACT
Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that bind and recruit an E3 ubiquitin ligase to a targeted protein of interest, often through the utilization of a small molecule inhibitor. To expand the possible range of kinase targets that can be degraded by PROTACs, we sought to develop a PROTAC utilizing a hydrocarbon-stapled peptide as the targeting agent to bind the surface of a target protein of interest. In this study, we describe the development of a proteolysis-targeting chimera, dubbed Stapled Inhibitor Peptide - PROTAC or StIP-TAC, linking a hydrocarbon-stapled peptide with an E3 ligase ligand for targeted degradation of Protein Kinase A (PKA). This StIP-TAC molecule stimulated E3-mediated protein degradation of PKA, and this effect could be reversed by the addition of the proteasomal inhibitor MG-132. Further, StIP-TAC treatment led to a significant reduction in PKA substrate phosphorylation. Since many protein targets of interest lack structural features that make them amenable to small molecule targeting, development of StIP-TACs may broaden the potential range of protein targets using a PROTAC-mediated proteasomal degradation approach.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Quinases Dependentes de AMP Cíclico / Proteólise Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Quinases Dependentes de AMP Cíclico / Proteólise Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article